Comprehensive resistance profiling of chronic myeloid leukaemia associated ABL1 variants against five tyrosine kinase inhibitors using prime editing.
Saved in:
| Title: | Comprehensive resistance profiling of chronic myeloid leukaemia associated ABL1 variants against five tyrosine kinase inhibitors using prime editing. |
|---|---|
| Authors: | Jung Y; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea., Yu G; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.; Graduate School of Medical Science, Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea., Oh HC; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea., Lee JH; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea., Jeon E; Graduate School of Medical Science, Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea., Bae J; Graduate School of Medical Science, Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea., Sim T; Graduate School of Medical Science, Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Clinical Candidate Discovery & Development Institute, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim HH; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea. hkim1@yuhs.ac.; Graduate School of Medical Science, Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea. hkim1@yuhs.ac.; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. hkim1@yuhs.ac.; Center for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea. hkim1@yuhs.ac.; Yonsei-IBS Institute, Yonsei University, Seoul, Republic of Korea. hkim1@yuhs.ac.; Woo Choo Lee Institute for Precision Drug Development, Yonsei University College of Medicine, Seoul, Republic of Korea. hkim1@yuhs.ac.; Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea. hkim1@yuhs.ac.; Won-Sang Lee Institute for Hearing Loss, Yonsei University College of Medicine, Seoul, Republic of Korea. hkim1@yuhs.ac. |
| Source: | Nature biomedical engineering [Nat Biomed Eng] 2026 Jul; Vol. 10 (7), pp. 1392-1409. Date of Electronic Publication: 2025 Oct 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101696896 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2157-846X (Electronic) Linking ISSN: 2157846X NLM ISO Abbreviation: Nat Biomed Eng Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41125871 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comprehensive resistance profiling of chronic myeloid leukaemia associated ABL1 variants against five tyrosine kinase inhibitors using prime editing. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jung+Y%22">Jung Y</searchLink>; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yu+G%22">Yu G</searchLink>; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.; Graduate School of Medical Science, Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Oh+HC%22">Oh HC</searchLink>; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JH%22">Lee JH</searchLink>; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jeon+E%22">Jeon E</searchLink>; Graduate School of Medical Science, Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Bae+J%22">Bae J</searchLink>; Graduate School of Medical Science, Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Sim+T%22">Sim T</searchLink>; Graduate School of Medical Science, Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Clinical Candidate Discovery & Development Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+HH%22">Kim HH</searchLink>; Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea. hkim1@yuhs.ac.; Graduate School of Medical Science, Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea. hkim1@yuhs.ac.; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. hkim1@yuhs.ac.; Center for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of Korea. hkim1@yuhs.ac.; Yonsei-IBS Institute, Yonsei University, Seoul, Republic of Korea. hkim1@yuhs.ac.; Woo Choo Lee Institute for Precision Drug Development, Yonsei University College of Medicine, Seoul, Republic of Korea. hkim1@yuhs.ac.; Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea. hkim1@yuhs.ac.; Won-Sang Lee Institute for Hearing Loss, Yonsei University College of Medicine, Seoul, Republic of Korea. hkim1@yuhs.ac. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101696896%22">Nature biomedical engineering</searchLink> [Nat Biomed Eng] 2026 Jul; Vol. 10 (7), pp. 1392-1409. <i>Date of Electronic Publication: </i>2025 Oct 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101696896 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2157-846X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222157846X%22">2157846X </searchLink><i>NLM ISO Abbreviation: </i>Nat Biomed Eng <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41125871 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41551-025-01531-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1392 Titles: – TitleFull: Comprehensive resistance profiling of chronic myeloid leukaemia associated ABL1 variants against five tyrosine kinase inhibitors using prime editing. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jung Y – PersonEntity: Name: NameFull: Yu G – PersonEntity: Name: NameFull: Oh HC – PersonEntity: Name: NameFull: Lee JH – PersonEntity: Name: NameFull: Jeon E – PersonEntity: Name: NameFull: Bae J – PersonEntity: Name: NameFull: Sim T – PersonEntity: Name: NameFull: Kim HH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2157-846X Numbering: – Type: volume Value: 10 – Type: issue Value: 7 Titles: – TitleFull: Nature biomedical engineering Type: main |
| ResultId | 1 |